Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

E. Blair Holladay

E. Blair Holladay

CEO, American Society for clinical pathology USA

Carol Apt

Carol Apt

South Carolina State University USA

Giuseppe  Scalabrino

Giuseppe Scalabrino

University of Milan Italy

Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine USA

Sergey  V Brodsky

Sergey V Brodsky

The Ohio State University USA

MariaTeresa Mascellino

MariaTeresa Mascellino

Sapienza University of Rome Italy

Reinhard Buettner

Reinhard Buettner

University Hospital Cologne Germany

Jim Zhai

Jim Zhai

Mayo Clinic USA

Euro Pathology 2018

About Conference

The 15th European Pathology Congress is going to be held at Paris, France during April 20-21, 2018 hosted by Conferences Series LLC. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium pathology analysis, leading universities and pathology analysis establishments creating the conference an ideal platform to share expertise in Pathology and related fields.

Conference Series Ltd Organizes 1000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. To know more about the conference series visit: http://www.conferenceseries.com/

Pathology is a major field in modern medical practice and diagnosis. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. The In vitro diagnostics market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. Diagnostic Medicine has $35 billion market, growth 5-7% yearly. Pathology labs will take approximately $15-16 billion in revenue, and they will spend roughly 12% of their revenues with their suppliers all over USA.

Pathology is a root cause to understand the mechanism of a disease. It is a subject for the professionals who looks beyond the clinical expectations. Pathology 2018 gathers all the extroverts under one roof of current advances.

Who Should Attend?

Practicing pathologist, pathologist in training and other healthcare professionals interested in the latest advances and techniques in the field. Another segment of target audience is Pharmaceutical researchers, Clinical organizations, Educational institutes. Anatomical Pathologists, Surgical Pathologists, Forensic Pathologists etc.

The 15th European Pathology Congress will exhibit the products and services from commercial and non-commercial organizations like Pathology Lab Equipment manufacturers, Cell Diagnostics laboratories, Clinical Trial Sites, Business delegates and Equipment Manufacturers.

Why to attend Euro Pathology 2018?

The essential global gathering of the pathologists & diagnostic medicine team: An unequaled experience— practical, personalized and innovative—with education and networking opportunities that will help you to bring your skills and knowledge to an entirely new level.

The 15th European Pathology Congress is your perfect opportunity to receive innovative, customizable education to support your current practice and prepare you for future success. It is your best chance of the year to join colleagues from around the globe to develop skills you can apply right now, see and understand the practices that are influencing your field, and prepare to be at the forefront of diagnostic medicine in the future

 

Market Analysis

The worldwide pathology statistical surveying report gives point by point data about the business in light of the income (USD MN) for the estimate time frame. The examination study is a spellbinding investigation of this market underscoring the market drivers and restrictions that administer the general market development. The patterns and future prospects for the market are likewise incorporated into the report which gives a scholarly comprehension of the pathology business. Besides, the report measures the piece of the overall industry held by the real players of the business and gives a top to bottom perspective of the aggressive scene. This market is characterized into various fragments with point by point investigation of each regarding geology for the review time frame.

Study period considered for research of global pathology market:

Base Year: 2016

Estimated Year: 2017

Forecast Till: 2022

A glimpse of the major drivers and restraints affecting the  pathology market is mentioned below:

Drivers

  • Rise in adoption of pathology to enhance lab efficiency
  • Increasing application of pathology in drug development and companion diagnostics
  • Ease of consultation enabled by pathology
  • Growing initiatives by governments and industry players
  • Growing number of research projects establishing the efficacy of  pathology

 Restraints

  • Higher cost of pathology systems
  • Regulatory concerns
  • Dearth in standard guidelines
  • Reluctance among pathologists to adopt advanced technologies

 

The report offers an esteem chain examination that gives a complete standpoint of the pathology advertise. The engaging quality investigation of this market has additionally been incorporated in order to assess the fragments that are expected to be beneficial amid the gauge time frame.

The pathology advertise has been divided in light of item, for example, scanner, programming, correspondence framework, and capacity framework. The review joins intermittent market gauges and estimates. Every item has been dissected in view of the market estimate at provincial and nation levels. The pathology advertise has been divided in light of sorts, for example, human pathology, and creature pathology. The review joins intermittent market gauges and estimates. Every sort has been dissected in view of the market estimate at local and nation levels.

The pathology advertise has been sectioned in light of uses, for example, teleconsultation, infection determination, medicate revelation, and instruction and preparing. The report gives conjecture and gauges to every application as far as market size amid the review time frame. Every application has been further dissected in light of provincial and nation levels.

The pathology advertise has been portioned in view of end client, for example, pharmaceutical, biotechnology organizations and CRO'S, doctor's facility and reference labs, and scholastic and government inquire about foundation. The review fuses intermittent market gauges and figures. Every end client has been examined in view of the market measure at territorial and nation levels.

Geologically, the pathology showcase has been fragmented into districts, for example, North America, Europe, Asia Pacific, and Rest of the World. The review points of interest nation level angles in view of every fragment and gives gauges as far as market size.

The report likewise concentrates the aggressive scene of the worldwide market with organization profiles of players, for example, Leica Biosystems Nussloch GMBH, Ventana Medical Systems, Inc., Hamamatsu Photonics K.K., 3dhistech Ltd., Philips Healthcare, Apollo Enterprise Imaging Corp.

Xifin, Inc., Definiens AG, Visiopharm A/S, Omnyx, LLC, and Corista LLC. A nitty gritty portrayal of each has been incorporated, with data regarding central command, commencement, stock posting, up and coming limits, key mergers and acquisitions, budgetary diagram, and late improvements. This investigation gives an intensive thought regarding the focused situating of market players. The report likewise gives data of pathology market's mergers/acquisitions, organizations, coordinated efforts, new item dispatches, new item advancements and other industry improvements.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

 

SEGMENTATIONS IN REPORT:

Pathology Market Analysis by Product:

  • Scanner
  • Software
  • Communication System
  • Storage System

 Pathology Market Analysis by Type:

  • Human Pathology
  • Animal Pathology

 Pathology Market Analysis by Applications:

  • Teleconsultation
  • Disease Diagnosis
  • Drug Discovery
  • Education and Training

 Pathology Market Analysis by End User:

  • Pharmaceutical, Biotechnology Companies & CRO’s
  • Hospital and Reference Laboratories
  • Academic and Government Research Institute

 Pathology Research Institutes in Europe continent:

  • London
  • UK
  • Rest of Europe

Global Market on Pathology

The Global  Pathology Market is assessed to be $191.00 million in 2012, and is ready to develop at a CAGR of 12% to reach $336.61 million by 2017.

 

This report thinks about the worldwide computerized pathology market over the conjecture time of 2013 to 2018. The business sector was assessed at $250.2 million in 2013 and is relied upon to reach $437 million by 2018, developing at a CAGR of 11.8% from 2013 to 2018. This report covers the definition, portrayal, and estimate of the computerized pathology market regarding items and applications. In view of items, the computerized pathology market contains scanners, investigation, stockpiling, and correspondence. The application business sector is sorted into human and creature pathology. Human pathology is sectioned into pharmaceutical and biotech organizations, doctor's facilities and reference labs, and preparing and training focuses, while creature pathology is portioned into pharmaceutical and biotechnology organizations, contract research associations and scholarly and government research foundations.

North America represented the biggest offer of the worldwide advanced pathology market, trailed by Europe and Asia. The predominance of the North American business sector can be credited to the good repayment situation in the U.S. what's more, the utilization of computerized pathology to enhance the nature of tumor determination in Canada. In any case, the Asian business sector is required to encounter the most astounding development in the computerized pathology market. The high development in this locale can be ascribed to the ascent in attention to advanced pathology and its advantages, community oriented endeavors by players, and government wellbeing offices empowering the utilization of computerized pathology to enhance the nature of malignancy finding. A percentage of the unmistakable players in the worldwide advanced pathology market incorporate 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).

Past Conference Report

Supported By

Journal of Clinical and Experimental Pathology Journal of Medical & Surgical Pathology Journal of Cellular & Molecular Pathology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by